Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment

Bello López, José Luis

Estatísticas

Estatísticas

Ver Estatísticas de uso

Identificadores

Identificadores

URI: http://hdl.handle.net/20.500.11940/3528

PMID: 23880897

DOI: 10.1097/MNM.0b013e328363c695

ISSN: 0143-3636

Rexistro completo

Servizos

Servizos

RIS

Mendeley

Linksolver

Data de publicación

2013

Título da revista

NUCLEAR MEDICINE COMMUNICATIONS

Tipo de contido

Artigo